Symptom profiles of natural and laboratory panic attacks

Acta Neuropsychiatrica

Volumn 16, Issue 2, 2004, Pages 101-106

  Schruers, K R J ^a   Van De Mortel, H ^a   Overbeek, T ^a   Griez, E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Carbon dioxide; Naturalistic; Panic; Symptom

Indexed keywords

CARBON DIOXIDE;

ADULT; AGED; ARTICLE; DAILY LIFE ACTIVITY; DIZZINESS; EXPERIMENTAL MODEL; FEMALE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; SYMPTOMATOLOGY; TREMOR;

EID: 1642421711     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0924-2708.2004.0084.x     Document Type: Article

References (44)

1. DICK CI, BLAND RC, NEWMAN SC. Epidemiology of psychiatric disorders in Edmonton. Panic disorder. Acta Psychiatr Scand 1994;90(Suppl 376):45-53.
2. VOLLRATH M, KOCH R, ANGST J. The Zurich Study. IX. Panic disorder and sporadic panic: symptoms, diagnosis, prevalence, and overlap with depression. Eur Arch Psychiatry Neurol Sci 1990;239:221-230.
3. BRIGGS AC, STRETCH DD, BRANDON S. Subtyping of panic disorder by symptom profile. Br J Psychiatry 1993;163:201-209.
4. SHIOIRI T, SOMEYA T, MURASHITA J, TAKAHASHI S. The symptom structure of panic disorder: a trial using factor and cluster analysis. Acta Psychiatr Scand 1996;93:80-86.
5. DE BEURS E, GARSSEN B, BOUIKHUISEN M, LANGE A, VAN BALKOM A, VAN DYCK R. Continuous monitoring of panic. Acta Psychiatr Scand 1994;90:38-45.
6. GUTTMACHER LB, MURPHY DL, INSEL TR. Pharmacologic models of anxiety. Compr Psychiatry 1983;24:312-326.
7. UHDE TW, TANCER ME. Chemical models of panic: a review and critique. In: TYRER P (ed). Psychopharmacology of anxiety. Oxford, UK: Oxford University Press, 1990.
8. VERBURG K, PERNA G, BELLODI L, GRIEZ E. The 35% panic provocation challenge as a diagnostic test for panic disorder. In: BELLODI L, PERNA G (eds). The panic respiration connection. Milan, Italy: Medical Media Srl, 1998.
9. 2) challenge in panic disorder patients. J Affect Disord 1998;49:195-201.
10. GRIEZ E, DE LOOF C, POLS H, ZANDBERGEN J, LOUSBERG H. Specific sensitivity of patients with panic attacks to carbon dioxide inhalation. Psychiatry Res 1990;31:193-199.
11. VERBURG K, POLS H, DE LEEUWM, GRIEZ E. Reliability of the 35% carbon dioxide panic provocation challenge. Psychiatry Res 1998;78:207-214.
12. VERBURG K, GRIEZ E, MEIJER J. A 35% carbon dioxide challenge in simple phobias. Acta Psychiatr Scand 1994;90:4204-423.
13. VERBURG K, GRIEZ E, MEIJER J, POLS H. Discrimination between panic disorder and generalized anxiety disorder by 35% carbon dioxide challenge. Am J Psychiatry 1995;152:1081-1083.
14. 2 challenge test in patients with social phobia. Psychiatry Res 1997;71:41-48.
15. GORMAN JM, PAPP LA, MARTINEZ J et al. High dose carbon dioxide challenge test in anxiety disorder patients. Biol Psychiatry 1990;28:743-757.
16. PAPP LA, KLEIN DF, MARTINEZ J et al. Diagnostic and substance specificity of carbon-dioxide-induced panic. Am J Psychiatry 1993;150:250-257.
17. PERNA G, GABRIELE A, CALDIROLA D, BELLODI L. Hypersensitivity to inhalation of carbon dioxide and panic attacks. Psychiatry Res 1995;57:267-273.
18. PERNA G, BATTAGLIA M, GARBERI A, ARANCIO C, BERTANI A, BELLODI L. 35% CO2/65% 02 inhalation test in panic patients. Psychiatry Res 1994;52:159-172.
19. PERNA G, BERTANI A, GABRIELE A, POLITI E, BELLODI L. Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol 1997;17:173-178.
20. BERTANI A, PERNA G, ARANCIO C, CALDIROLA D, BELLODI L. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study. J Clin Psychopharmacol 1997;17:97-101.
21. SCHMIDT NB, TRAKOWSKI JH, STAAB JP. Extinction of panicogenic effects of a 35% CO2 challenge in patients with panic disorder. J Abnorm Psychol 1997;106:630-638.
22. VAN DEN HOUT MA, VAN DER MOLEN GM, GRIEZ E, LOUSBERG H, JANSEN A. Reduction of CO2-induced anxiety in patients with panic attacks after repeated CO2 exposure. Am J Psychiatry 1987;144:788-791.
23. POLS H, ZANDBERGEN J, DE LOOF C, GRIEZ E. Attenuation of carbon dioxide-induced panic after clonazepam treatment. Acta Psychiatr Scand 1991;84:585-586.
24. POLS H, LOUSBERG H, ZANDBERGEN J, GRIEZ E. Panic disorder patients show decrease in ventilatory response to CO2 after clomipramine treatment. Psychiatry Res 1993;47:295-296.
25. POLS HJ, HAUZER RC, MEIJER JA, VERBURG K, GRIEZ EJ. Fluvoxamine attenuates panic induced by 35% CO2 challenge. J Clin Psychiatry 1996;57:539-542.
26. GORMAN JM, BROWNE ST, PAPP LA et al. Effect of antipanic treatment on response to carbon dioxide. Biol Psychiatry 1997;42:982-991.
27. NARDI AE, VALENCA AM, ZIN WA, FIGUIERA I, MARQUES C, VERSIASSI M. Short term clonezepam treatment in carbon dioxide induced panic attacks. J Bras Psig 1997;46:611-614.
28. BOCOLA V, TRECCO MD, FABBRINI G, PALADINI C, SOLLECITO A, MARTUCCI N. Antipanic effect of fluoxetine measured by CO2 challenge test. Biol Psychiatry 1998;43:612-615.
29. GRIEz EJ, LOUSBERG H, VAN DEN HouT MA, VAN DER MOLEN GM. CO2 vulnerability in panic disorder. Psychiatry Res 1987;20:97-95.
30. DE LOOF C, ZANDBERGEN J, GRIEZ E. Are there differences between naturally occuring and provoked panic attacks? The case of carbon dioxide induced panic attacks. In: SOLDATES C, RABAVILLES A (eds). Psychiatry today. Amsterdam, The Netherlands: Elsevier science publishers, 1990.
31. KLAASSEN T, KLUMPERBEEK J, DEUTZ NE, VAN PRAAG HM, GRIEZ E. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res 1998;77:167-174.
32. ARGYLE N, ROTH M. The definition of panic attacks, Part I. Psychiatr Dev 1989;7:175-186.
33. BEITMAN BD, BASHA I, FLAKER G et al. Atypical or nonanginal chest pain. Panic disorder or coronary artery disease? Arch Intern Med 1987;147:1548-1552.
34. SERLIE AW, ERDMAN RA, PASSCHIER J, TRIJSBURG RW, TEN CATE FJ. Psychological aspects of non-cardiac chest pain. Psychother Psychosom 1995;64:62-73.
35. FLEET RP, DUPUIS G, MARCHAND A, BURELLE D, ARSENAULT A, BEITMAN BD. Panic disorder in emergency department chest pain patients: prevalence, comorbidity, suicidal ideation, and physician recognition. Am J Med 1996;101:371-380.
36. FLEET RP, BEITMAN BD. Unexplained chest pain: when is it panic disorder? Clin Cardiol 1997;20:187-194.
37. KUIJPERS PM, HONIG A, GRIEZ EJ, BRAAT SH, WELLENS HJ. Paniekstoornissen, pijn op de borst en palpitaties: een pilotonderzoek op een Nederlandse Eerste Harthulp. Ned Tijdschr Geneeskd 2000;144:745-749.
38. SCHRUERS K, KUIJPERS PM, HONIG A, GRIEZ E. Panic symptoms determine type of health care. Poster at the 14th conference of the European Health Psychology Society, Leiden, The Netherlands, 16-19 August 2000.
39. BIBER B, ALKiN T. Panic disorder subtypes: differential responses to CO2 challenge. Am J Psychiatry 1999;156:739-744.
40. CASSANO GB, PETRACCA A, PERUGI G, TONI C, TUNDO A, ROTH M. Derealization and panic attacks: a clinical evaluation on 150 patients with panic disorder/agoraphobia. Compr Psychiatry 1989;30:5-12.
41. MAVISSAKALIAN MR, PEREL JM. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder. Psychopharmacol Bull 1996;32:143-147.
42. KOSZYCKI D, BRADWEJN J, BOURIN M. Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers. Eur Neuropsychopharmacol 1991;1:137-141.
43. 2 inhalation test in panic patients. Psychiatry Res 1994;52:159-172.
44. KLEIN DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 1993;50:306-317.